Once we have the COVID-19 vaccine, will we use it? This was the motto for a paper published in The European Journal of Health Economics and addressed by Tempo Medicina. Nova SBE joined the University of Hamburg, Rotterdam Erasmus University and Bocconi University to learn how the European population deals with the threat of the virus and if they trust and follow political decisions around the pandemic. The conclusions of the second wave of the survey involving Germany, Denmark, France, the Netherlands, Italy, Portugal and the United Kingdom are now known, revealing that 75% of the Portuguese respondents intend to be vaccinated against COVID-19 and that 70% are completely confident that the vaccine will be safe; 21% showed indecision and only 5% said they did not want to be vaccinated. Pedro Pita Barros, one of the authors of the survey Once we have it, will we use it? The European survey on willingness to be vaccinated against Covid 19, revealed that globally “18.9% of respondents answered they were not sure while 7.2% don’t want to be vaccinated.” This willingness to be vaccinated ranged from “62% in France to approximately 80% in Denmark and the United Kingdom. Germany and France were the countries where most people were against vaccination (10% in each) and France was also the country with the most undecided about vaccination (28%).” According to the authors, “although currently the focus of attention is on the development of a vaccine against SARS-CoV-2, policy makers must prepare for the next challenge: the adoption of the vaccine among the public, as having a vaccine does not automatically imply that it will be administered”. To learn more about this study see  https://www.hche.uni-hamburg.de/en/forschung/corona.html